Related Experiment Video

Updated: May 13, 2026

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets
06:35

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets

Published on: March 29, 2024

Pharmacological approaches to the treatment of oxidative stress-induced cardiovascular dysfunctions

Pedro L Zamora1, Frederick A Villamena

  • 1Department of Pharmacology, & Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.

Future Medicinal Chemistry
|March 19, 2013
PubMed

Insights

Cardiovascular diseases are a growing global health issue. This review explores new antioxidant therapies targeting oxidative stress, as conventional treatments for heart failure show limited long-term efficacy.

Area of Science:

  • Cardiology and Molecular Medicine

Background:

  • Cardiovascular diseases (CVDs) represent a significant and increasing global health burden.
  • Oxidative stress is increasingly recognized as a critical factor in the pathophysiology of CVDs.
  • Conventional antioxidant therapies have demonstrated limited success in treating conditions like heart failure.

Purpose of the Study:

  • To review current therapeutic targets and compounds for treating cardiovascular diseases.
  • To focus on strategies that inhibit oxidative stress as a primary mechanism.
  • To address the unmet need for novel treatments due to the limitations of existing therapies.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of therapeutic strategies targeting oxidative stress in cardiovascular disease models.
  • Compilation of data on novel compounds and their mechanisms of action.

Main Results:

  • Identification of various molecular targets implicated in oxidative stress-related cardiovascular dysfunction.
  • Presentation of a range of antioxidant compounds with potential therapeutic applications.
  • Discussion of the challenges and future directions in developing effective antioxidant therapies for CVDs.

Conclusions:

  • Novel therapeutic strategies targeting oxidative stress are crucial for managing cardiovascular diseases.
  • Further research is needed to translate promising antioxidant compounds into effective clinical treatments.
  • Addressing oxidative stress offers a promising avenue for improving outcomes in cardiovascular disease patients.

More Related Videos

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors09:33

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors

Published on: February 7, 2018

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...